Cargando…

Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating pandemic worldwide. Vaccines and antiviral drugs are the most promising candidates for combating this global epidemic, and scientists all over the world have made great efforts to this end. However, manipulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bei, Zhang, Chongyang, Lei, Xiaobo, Ren, Lili, Zhao, Zhendong, Wang, Jianwei, Huang, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034055/ https://www.ncbi.nlm.nih.gov/pubmed/33835389 http://dx.doi.org/10.1007/s12250-021-00369-9

Ejemplares similares

Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function
por: Wang, Jian-Min, et al.
Publicado: (2008)

Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
por: Nguyen, Hai Trong, et al.
Publicado: (2021)

A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis
por: Feng, Xiaolong, et al.
Publicado: (2022)

Construction and Applications of Rabbit Hemorrhagic Disease Virus Replicon
por: Wang, Binbin, et al.
Publicado: (2013)

Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
por: Takazawa, Shunta, et al.
Publicado: (2023)

Replication and single-cycle delivery of SARS-CoV-2 replicons
por: Ricardo-Lax, Inna, et al.
Publicado: (2021)

SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery
por: Jin, Yun-Yun, et al.
Publicado: (2021)

High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery
por: Ge, Feng, et al.
Publicado: (2008)

Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening
por: Tanaka, Tomohisa, et al.
Publicado: (2022)

A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization
por: Liu, Ying, et al.
Publicado: (2022)

Activation and evasion of type I interferon responses by SARS-CoV-2
por: Lei, Xiaobo, et al.
Publicado: (2020)

A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
por: Kotaki, Tomohiro, et al.
Publicado: (2021)

Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon
por: Nakamura, Akina, et al.
Publicado: (2022)

Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
por: He, Xi, et al.
Publicado: (2021)

Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories
por: Malicoat, Johnny, et al.
Publicado: (2022)

Coronavirus reverse genetic systems: Infectious clones and replicons
por: Almazán, Fernando, et al.
Publicado: (2014)

Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release
por: Tian, Lingqian, et al.
Publicado: (2022)

A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2
por: Zhang, Yang, et al.
Publicado: (2021)

Construction of a mini-RNA replicon in Escherichia coli
por: Kashiwagi, Akiko, et al.
Publicado: (2023)

Assessment of Antibody and T-Cell Responses to the SARS-CoV-2 Virus and Omicron Variant in Unvaccinated Individuals Recovered From COVID-19 Infection in Wuhan, China
por: Guo, Li, et al.
Publicado: (2022)

Derivation of a novel SARS–coronavirus replicon cell line and its application for anti-SARS drug screening
por: Ge, Feng, et al.
Publicado: (2007)

Reprint of: Coronavirus reverse genetic systems: Infectious clones and replicons()
por: Almazán, Fernando, et al.
Publicado: (2014)

Zika Virus Replicons for Drug Discovery
por: Xie, Xuping, et al.
Publicado: (2016)

SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron
por: Zhu, Yuanmei, et al.
Publicado: (2022)

Development of A MERS-CoV Replicon Cell Line for Antiviral Screening
por: Chen, Jing, et al.
Publicado: (2021)

Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape
por: Dang, Shengyuan, et al.
Publicado: (2022)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020)

Viral replicons as valuable tools for drug discovery
por: Hannemann, Holger
Publicado: (2020)

Development of Mouse Hepatitis Virus and SARS-CoV Infectious cDNA Constructs
por: Baric, R. S., et al.
Publicado: (2005)

DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice
por: Szurgot, Inga, et al.
Publicado: (2021)

SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation
por: Wang, Wenjing, et al.
Publicado: (2021)

Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2021)

Screening for inhibitors against SARS-CoV-2 and its variants
por: Yuan, Weijing, et al.
Publicado: (2022)

A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022)

HCV Replicon Systems: Workhorses of Drug Discovery and Resistance
por: Khan, Shaheen, et al.
Publicado: (2020)

Construction of a Chikungunya Virus, Replicon, and Helper Plasmids for Transfection of Mammalian Cells
por: Colunga-Saucedo, Mayra, et al.
Publicado: (2022)

Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants
por: Yu, Danwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fipp978b5j6inm2iupjqpa7lal